Regulation of IL4 gene expression by T cells and therapeutic perspectives

Nature Reviews Immunology

Volumn 3, Issue 7, 2003, Pages 534-543

  Li Weber, Min ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; CYCLOSPORIN A; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; PARTHENOLIDE; TACROLIMUS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; DIET; DIET SUPPLEMENTATION; DRUG TARGETING; DRUG TOXICITY; EFFECTOR CELL; ENHANCER REGION; GENE; GENE EXPRESSION REGULATION; GENETIC CODE; GRAFT VERSUS HOST REACTION; HAY FEVER; HELMINTH; HELPER CELL; HUMAN; HUMORAL IMMUNITY; INTERLEUKIN 4 GENE; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TH2 CELL;

ANIMALS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0142197612     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1128     Document Type: Review

References (152)

1. H2 effector choice in parasitic infection: decision making by committee. Curr. Opin. Immunol. 13, 403-409 (2001).
2. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933-944 (2002).
3. H2 cells in Stat4-deficient mice. Nature 382, 174-177 (1996).
4. Magram, J. et al. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4, 471-481 (1996).
5. Thierfelder, W. E. et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174 (1996).
6. H2 cells. J. Exp. Med. 185, 817-824 (1997).
7. Ma, X. et al. The interleukin 12 p40 gene promoter is primed by interferon-γ in monocytic cells. J. Exp. Med. 183, 147-157 (1996).
8. Lighvani, A. A. et al. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl Acad. Sci. USA 98, 15137-15142 (2001).
9. + T cells. Nature Immunol. 3, 549-557 (2002).
10. H1 lineage commitment. Cell 100, 655-669 (2000).
11. Elser, B. et al. IFN-γ represses IL-4 expression via IRF-1 and IRF-2. Immunity 17, 703-712 (2002). This was the first study to show that interferon-γ (IFN-γ) directly suppresses transcription of the gene encoding interleukin-4 (IL-4).
12. Bradding, P. The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3, 45-50 (2003).
13. H2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
14. H2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597-21603 (1997).
15. H2 cytokines. Immunity 10, 745-751 (1999).
16. Tanaka, T., Hu-Li, J., Seder, R. A., Fazekas de St Groth, B. & Paul, W. E. Interleukin 4 suppresses interleukin 2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl Acad. Sci. USA 90, 5914-5918 (1993).
17. Goenka, S. et al. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. J. Immunol. 163, 4663-4672 (1999).
18. H1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755 (1998).
19. H1 differentiation by IL-6 is mediated by SOCS 1. Immunity 13, 805-815 (2000).
20. Diehl, S. et al. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196, 39-49 (2002).
21. O'Shea, J. J., Ma, A. & Lipsky, P. Cytokines and autoimmunity. Nature Rev. Immunol. 2, 37-45 (2002).
22. Tepper, R. I. et al. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62, 457-467 (1990).
23. H2-like cells in atopic individuals. J. Invest. Allergol. Clin. Immunol. 7, 144-150 (1997).
24. H2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2, 66-70 (2001).
25. Snappe, C. M. & Paul, W. E. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947 (1987). This study was one of the first to show that IL-4 regulates the production of immunoglobulin E.
26. Wynn, T. A. IL-13 effector functions. Annu. Rev. Immunol. 21, 425-456 (2003).
27. Mayr, S. I. et al. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J. Immunol. 169, 2061-2068 (2002).
28. Kawakami, T. & Galli, S. J. Regulation of mast-cell and basophil function and survival by IgE. Nature Rev. Immunol. 2, 773-786 (2002).
29. Lukacs, N. W. Role of chemokines in the pathogenesis of asthma. Nature Rev. Immunol. 1, 108-116 (2001).
30. Foster, P. S., Hogan, S. P., Ramsay, A. J., Matthaei, K. I. & Young, I. G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183, 195-201 (1996).
31. H1 cells. J. Exp. Med. 192, 105-115 (2000).
32. H2-specific cytokine gene cluster. J. Immunol. 165, 6687-6691 (2000).
33. Agarwal, S., Avni, O. & Rao, A. Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity 12, 643-652 (2000). This study identified nuclear factor of activated T cells (NFAT)-binding sites in the 3′ region of the gene encoding IL-4.
34. Lee, G. R., Fields, P. E. & Flavell, R. A. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14, 447-459 (2001).
35. H2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
36. Zhang, D. H., Yang, L. & Ray, A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821 (1998).
37. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826 (1998).
38. Loots, G. G. et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136-140 (2000).
39. H2-specific cytokine gene cluster. J. Immunol. 165, 6687-6691 (2000).
40. Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747 (1997).
41. Macian, F., Lopez-Rodriguez, C. & Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 20, 2476-2489 (2001).
42. Abe, E., De Waal Malefyt, R., Matsuda, I., Arai, K. & Arai, N. An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl Acad. Sci. USA 89, 2864-2868 (1992).
43. Szabo, S. J., Gold, J. S., Murphy, T. L. & Murphy, K. M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13, 4793-4805 (1993).
44. Chuvpilo, S. et al. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21, 5694-5704 (1993).
45. Burke, T. F., Casolaro, V. & Georas, S. N. Characterization of P5, a novel NFAT/AP-1 site in the human IL-4 promoter Biochem. Biophys. Res. Commun. 270, 1016-1023 (2000). References 43-45 show that the promoter of the gene encoding IL-4 contains many NFAT-binding sites.
46. Ranger, A. M. et al. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8, 125-134 (1998).
47. H2 cytokine production. Immunity 8, 115-124 (1998).
48. Xanthoudakis, S. et al. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272, 892-895 (1996).
49. H2 cell differentiation by a mechanism involving NFAT1. Immunity 7, 849-860 (1997).
50. Viola, J. P., Kiani, A., Bozza, P. T. & Rao, A. Regulation of allergic inflammation and eosinophil recruitment in mice lacking the transcription factor NFAT1: role of interleukin-4 (IL-4) and IL-5. Blood 91, 2223-2230 (1998).
51. Hodge, M. R. et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 397-405 (1996).
52. H2-type lymphokines. Immunol. Lett. 57, 171-175 (1997).
53. Schuh, K. et al. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur. J. Immunol. 28, 2456-2466 (1998).
54. Peng, S. L., Gerth, A. J., Ranger, A. M. & Glimcher, L. H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14, 13-20 (2001).
55. Monticelli, S. & Rao, A. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32, 2971-2978 (2002). References 54 and 55 show that both NFAT1 and NFAT2 are important for expression of the gene encoding IL-4.
56. H2 cytokines.
57. H cells. Nature Immunol. 3, 48-54 (2002).
58. Isakov, N. & Altman, A. Protein kinase Cθ in T cell activation. Annu. Rev. Immunol. 20, 761-794 (2002).
59. Arendt, C. W., Albrecht, B., Soos, T. J. & Littman, D. R. Protein kinase Cθ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14, 323-330 (2002).
60. H2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. J. Immunol. 161, 1380-1389 (1998).
61. Rooney, J. W., Hoey, T. & Glimcher, L. H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2, 473-483 (1995).
62. Takemoto, N., Koyano-Nakagawa, N., Arai, N., Arai, K. & Yokota, T. Four P-like elements are required for optimal transcription of the mouse IL-4 gene: involvement of a distinct set of nuclear factor of activated T cells and activator protein-1 family proteins. Int. Immunol. 9, 1329-1338 (1997).
63. Li-Weber, M., Salgame, P., Hu, C., Davydov, I. V. & Krammer, P. H. Differential interaction of nuclear factors with the PRE-I enhancer element of the human IL-4 promoter in different T cell subsets. J. Immunol. 158, 1194-1200 (1997).
64. Li-Weber, M., Salgame, P., Hu, C. & Krammer, P. H. Characterization of constitutive and inducible transcription factors binding to the P2 NF-AT site in the human interleukin-4 promoter. Gene 188, 253-260 (1997).
65. Li-Weber, M., Giasi, M. & Krammer, P. H. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273, 32460-32466 (1998). This study was the first to show that NF-κB activates transcription of the gene encoding IL-4.
66. Li, B., Tournier, C., Davis, R. J. & Flavell, R. A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18, 420-432 (1999).
67. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J. & Flavell, R. A. Defective T cell differentiation in the absence of Jnk1. Science 282, 2092-2095 (1998).
68. H1 cells requires MAP kinase JNK2. Immunity 9, 575-585 (1998).
69. Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000).
70. Sun, Z. et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404, 402-407 (2000).
71. Frantz, B. et al. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13, 861-870 (1994).
72. Venkataraman, L., Burakoff, S. J. & Sen, R. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181, 1091-1099 (1995).
73. Marienfeld, R. et al. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitors, but not with the processing of p105/NF-κB1 in T cells. Eur. J. Immunol. 27, 1601-1609 (1997).
74. Hehner, S. P. et al. Vav synergizes with protein kinase Cθ to mediate IL-4 gene expression in response to CD28 costimulation in T cells. J. Immunol. 164, 3829-3836 (2000).
75. Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R. P. & Bravo, R. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2. J. Exp. Med. 186, 999-1014 (1997).
76. Ferreira, V. et al. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J. Immunol. 162, 6442-6450 (1999).
77. Donovan, C. E. et al. NF-κB/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163, 6827-6833 (1999).
78. Yang, L. et al. Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188, 1739-1750 (1998).
79. Rodriguez-Palmero, M., Hara, T., Thumbs, A. & Hunig, T. Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo. Eur. J. Immunol. 29, 3914-3924 (1999).
80. H2 differentiation in allergic airway inflammation. Nature Immunol. 2, 45-50 (2001).
81. Ramji, D. P. & Foka, P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575 (2002).
82. Kinoshita, S., Akira, S. & Kishimoto, T. A member of the C/EBP family. NF-IL6β, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc. Natl Acad. Sci. USA 89, 1473-1476 (1992).
83. LeClair, K. P., Blanar, M. A. & Sharp, P. A. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc. Natl Acad. Sci. USA 89, 8145-8149 (1992).
84. Stein, B., Cogswell, P. C. & Baldwin, A. S. Jr. Functional and physical associations between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13, 3964-3974 (1993).
85. Matsusaka, T. et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl Acad. Sci. USA 90, 10193-10197 (1993).
86. Kunsch, C., Lang, R. K., Rosen, C. A. & Shannon, M. F. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153, 153-164 (1994).
87. Hsu, W., Kerppola, T. K., Chen, P. L., Curran, T. & Chen-Kiang, S. Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. Cell. Biol. 14, 268-276 (1994).
88. Davydov, I. V., Bohmann, D., Krammer, P. H. & Li-Weber, M. Cloning of the cDNA encoding human C/EBPγ, a protein binding to the PRE-I enhancer element of the human interleukin-4 promoter. Gene 161, 271-275 (1995).
89. Li-Weber, M. et al. What controls tissue-specific expression of the IL-4 gene? Immunobiology 198, 170-178 (1997).
90. Davydov, I. V., Krammer, P. H. & Li-Weber, M. Nuclear factor-IL6 activates the human IL-4 promoter in T cells. J. Immunol. 155, 5273-5279 (1995).
91. Berberich-Siebelt, F. et al. C/EBPβ enhances IL-4 but impairs IL-2 and IFN-γ induction in T cells. Eur. J. Immunol. 30, 2576-2585 (2000). References 90 and 91 show that NF-IL6 activates transcription of the gene encoding IL-4.
92. Mamane, Y., Sharma, S., Grandvaux, N., Hernandez, E. & Hiscott, J. IRF-4 activities in HTLV-1-induced T cell leukemogenesis J. Interferon Cytokine Res. 22, 135-143 (2002).
93. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001).
94. Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127-2136 (1995).
95. Yamagata, T. et al. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16, 1283-1294 (1996).
96. Grumont, R. J. & Gerondakis, S. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor κB. J. Exp. Med. 191, 1281-1292 (2000).
97. Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543 (1997).
98. Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012 (2002).
99. Lohoff, M. et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl Acad. Sci. USA 99, 11808-11812 (2002).
100. Casolaro, V. et al. Identification and characterization of a critical CP2-binding element in the human interleukin-4 promoter. J. Biol. Chem. 275, 36605-36611 (2000).
101. Li-Weber, M., Davydov, I. V., Krafft, H. & Krammer, P. H. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153, 4122-4133 (1994).
102. Shi, Y., Seto, E., Chang, L. S. & Shenk, T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67, 377-388 (1991).
103. Thomas, M. J. & Seto, E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236, 197-208 (1999).
104. Guo, J. et al. Yin-Yang 1 activates interleukin-4 gene expression in T cells. J. Biol. Chem. 276, 48871-48878 (2001).
105. Harada, H. et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729-739 (1989).
106. Miyamoto, M. et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54, 903-913 (1988).
107. Nelson, N. et al. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 156, 3711-3720 (1996).
108. Matsuyama, T. et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97 (1993).
109. Taki, S. et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679 (1997).
110. Lohoff, M. et al. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6, 681-689 (1997).
111. Lohoff, M. et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 192, 325-336 (2000).
112. Gourley, T. et al. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10, 377-386 (1999).
113. Sisk, T. J., Gourley, T., Roys, S. & Chang, C. H. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J. Immunol. 165, 2511-2517 (2000).
114. Oukka, M. et al. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9, 295-304 (1998).
115. + T cells. J. Immunol. 170, 3109-3117 (2003).
116. Klein-Hessling, S., Schneider, G., Heinfling, A., Chuvpilo, S. & Serfling, E. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells. Proc. Natl Acad. Sci. USA 93, 15311-15316 (1996).
117. Sigal, N. H. & Dumont, F. J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10, 519-560 (1992).
118. Su, B. et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736 (1994).
119. Avraham, A., Jung, S., Samuels, Y., Seger, R. & Ben-Neriah, Y. Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes. Eur. J. Immunol. 28, 2320-2330 (1998).
120. Schriber, S. L. & Crabtree, G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13, 136-142 (1992).
121. Meyer, S., Kohler, N. G. & Joly, A. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation. FEBS Lett. 413, 354-358 (1997).
122. Sigal, N. H. et al. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 173, 619-628 (1991).
123. Dumont, F. J. et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176, 751-760 (1992).
124. Moriguchi, S. & Muraga, M. Vitamin E and immunity. Vitam. Horm. 59, 305-336 (2000).
125. Shor-Posner, G. et al. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus-1 disease. J. Allergy Clin. Immunol. 95, 886-892 (1995).
126. Fogarty, A., Lewis, S., Weiss, S. & Britton, J. Dietary vitamin E, IgE concentrations, and atopy. Lancet 356, 1573-1574 (2000).
127. Wang, Y., Huang, D. S., Wood, S. & Watson, R. R. Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS. Immunopharmacology 29, 225-233 (1995).
128. Zheng, K. et al. Effect of dietary vitamin E supplementation on murine nasal allergy. Am. J. Med. Sci. 318, 49-54 (1999).
129. Li-Weber, M., Glaisi, M., Treiber, M. K. & Krammer, P. H. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur. J. Immunol. 32, 2401-2408 (2002).
130. Devadas, S., Zantskaya, L., Rhee, S. G., Oberley L. & Williams, M. S. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195, 59-70 (2002).
131. Gius, D., Botero, A., Shah, S. & Curry, H. A. Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1. Toxicol. Lett. 106, 93-106 (1999).
132. Mercurio, F. & Manning, A. M. NF-κB as a primary regulator of the stress response. Oncogene 18, 6163-6171 (1999).
133. Boscoboinik, D., Szewczyk, A., Hensey, C. & Azzi, A. Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C. J. Biol. Chem. 266, 6188-6194 (1991).
134. Wang, Y., Huang, D. S., Liang, B. & Watson, R. R. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J. Nutr. 124, 2024-2032 (1994).
135. Adolfsson, O., Huber, B. T. & Meydani, S. N. Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J. Immunol. 167, 3809-3817 (2001).
136. Meydani, S. N. et al. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am. J. Clin. Nutr. 68, 311-318 (1998).
137. Li-Weber, M. et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J. Clin. Invest. 110, 681-690 (2002).
138. Tak, P. P. & Firestein, G. S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11 (2001).
139. Hehner, S. P. et al. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β. J. Biol. Chem. 273, 1288-1297 (1998).
140. Hehner, S. P., Hofmann, T. G., Droge, W. & Schmitz, M. L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J. Immunol. 163, 5617-5623 (1999).
141. Garcia-Pineres, A. J. et al. Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J. Biol. Chem. 276, 39713-39720 (2001).
142. Li-Weber, M., Giaisi, M., Treiber, M. K. & Krammer, P. H. The anti-inflammatory sesquiterpene lactone parthenolide suppresses IL-4 gene expression in peripheral blood T. Eur. J. Immunol. 32, 3587-3597 (2002).
143. Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231, 232-235 (1971).
144. Kopp, E. & Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265, 956-959 (1994).
145. Yin, M. J., Yamamoto, Y. & Gaynor, R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396, 77-80 (1998).
146. Dong, Z., Huang, C., Brown, R. E. & Ma, W. Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 272, 9962-9970 (1997).
147. Cianferoni, A. et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 97, 1742-1749 (2001).
148. Reinemer, P., Sebald, W. & Duschl, A. The interleukin-4-receptor: from recognition mechanism to pharmacological target structure. Angew. Chem. Int. Ed. Engl. 39, 2834-2846 (2000).
149. H2 immune responses: a sufficient strategy? Curr. Opin. Immunol. 14, 644-651 (2002).
150. Ho, I. C., Hodge, M. R., Rooney, J. W. & Glimcher, L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983 (1996).
151. Porter, C. M., Havens, M. A. & Clipstone, N. A. Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization. J. Biol. Chem. 275, 3543-3551 (2000).
152. H2-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1. Mol. Cell. Biol. 20, 5227-5234 (2000).